Influenza virus vaccine - Chiron Vaccines

Drug Profile

Influenza virus vaccine - Chiron Vaccines

Latest Information Update: 03 Jun 2004

Price : *
* Final gross price and currency may vary according to local VAT and billing address.

At a glance

  • Originator Chiron Vaccines
  • Class Influenza virus vaccines
  • Mechanism of Action Immunostimulants
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No

Highest Development Phases

  • Discontinued Influenza virus infections

Most Recent Events

  • 03 Jun 2004 Discontinued - Phase-I for Influenza virus infections in United Kingdom (Intradermal)
  • 29 Sep 2003 Data presented at the 43rd Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC-2003) have been added to the adverse reactions and immunogenicity sections ,
  • 26 Aug 2003 PowderJect Pharmaceuticals has been acquired by Chiron Corporation
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top